Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Aslam, M
Al-Zaidy SA, Sahenk Z, Rodino-Klapac LR, Kaspar B, Mendell JR
Path 2: Moderate BMI + Serious Health Condition BMI of 30 or higher PLUS one of these: Heart failure (ask your doctor if you have "preserved ejection fraction" type) High blood pressure that's hard to control (still above 140/90 despite 2+ medicines) Chronic kidney disease (stage 3a or higher your doctor can confirm) Path 3: Lower BMI + Heart/Stroke History BMI of 27 or higher PLUS one of these: Pre-diabetes Previous heart attack Previous stroke Peripheral artery disease with symptoms (leg pain when walking) Important timing: These requirements are based on when you FIRST started the GLP-1 medication not your current weight or health
Research Use Only (RUO) CJC-1295 (No DAC) and Ipamorelin are synthetic peptides that are frequently studied together in laboratory research involving growth hormone signaling and endocrine physiology
US$ 23.32
US$ 28.31
US$ 22.19
US$ 21.66
